Optiscan Imaging (ASX:OIL) entered a collaborative research agreement with the University of Minnesota College of Veterinary Medicine, according to a Monday filing with the Australian bourse.
As part of the agreement, both parties will use the University's extensive research facilities to explore clinical applications of Optiscan Imaging's technology in veterinary medicine, the filing said.
The research will focus initially on advancing the diagnosis and treatment of cancer in companion animals.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments